Structure Therapeutics Inc. (GPCR)
Data as of , from SEC Form 4 filings.
See up to 3 months of GPCR. The 7-day demo opens the 1M and 3M ranges and puts GPCR on your watchlist.
Start 7-day demoLatest GPCR insider trades
About Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
- SOUTH SAN FRANCISCO, CA
- 281
- 2023
- XNAS
GPCR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 35,277 | $1.70M |
| Grant or award | 2 | 315,378 | |
| Option exercise | 6 | 82,902 | |
GPCR insider transactions (Form 4)
2443 Form 4 filings on record, the earliest from Jun 23, 2025, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Crespo Blas Coll - Officer | Tax withholding / forfeiture | Ordinary Shares | 8,106 | $7.74 | $63K | |
| Ashley Hall - Officer | Tax withholding / forfeiture | Ordinary Shares | 6,021 | $7.74 | $47K | |
| FMR LLC | Open-market sale | American Depositary Shares | 26,310 | $17.87 | $470K | |
| Crespo Blas Coll - Officer | Tax withholding / forfeiture | Ordinary Shares | 1,233 | $7.92 | $10K | |
| Crespo Blas Coll - Officer | Grant or award | Ordinary Shares | 7,992 | $0.00 | - | |
| Crespo Blas Coll - Officer | Tax withholding / forfeiture | Ordinary Shares | 1,434 | $6.84 | $10K | |
| Crespo Blas Coll - Officer | Grant or award | American Depositary Shares | 429 | $0.00 | - | |
| Yingli Ma - Officer | Tax withholding / forfeiture | Ordinary Shares | 1,824 | $7.92 | $14K | |
| Yingli Ma - Officer | Grant or award | Ordinary Shares | 24,459 | $0.00 | - | |
| Xichen Lin - Officer | Tax withholding / forfeiture | Ordinary Shares | 6,441 | $7.92 | $51K | |
| Xichen Lin - Officer | Grant or award | Ordinary Shares | 57,078 | $0.00 | - | |
| Jun Yoon - Officer | Tax withholding / forfeiture | Ordinary Shares | 5,940 | $7.92 | $47K | |
| Jun Yoon - Officer | Grant or award | Ordinary Shares | 39,606 | $0.00 | - | |
| Jun Yoon - Officer | Tax withholding / forfeiture | Ordinary Shares | 7,089 | $6.84 | $48K | |
| Jun Yoon - Officer | Grant or award | American Depositary Shares | 831 | $0.00 | - | |
| Raymond C. Stevens - Officer | Tax withholding / forfeiture | Ordinary Shares | 12,495 | $7.92 | $99K | |
| Raymond C. Stevens - Officer | Grant or award | Ordinary Shares | 89,697 | $0.00 | - | |
| Raymond C. Stevens - Officer | Tax withholding / forfeiture | Ordinary Shares | 16,050 | $6.84 | $110K | |
| Raymond C. Stevens - Officer | Grant or award | American Depositary Shares | 1,000 | $0.00 | - | |
| Yingli Ma - Officer | Tax withholding / forfeiture | Ordinary Shares | 4,470 | $6.84 | $31K | |
| Xichen Lin - Officer | Tax withholding / forfeiture | Ordinary Shares | 12,846 | $6.84 | $88K | |
| Daniel G. Welch | Grant or award | Share Option (right to buy) | 51,804 | $0.00 | - | |
| Eric Dobmeier | Grant or award | Share Option (right to buy) | 51,804 | $0.00 | - | |
| Ted W. Love | Grant or award | Share Option (right to buy) | 51,804 | $0.00 | - |
Recent GPCR Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| BLAS COLL CRESPO | Officer | 4,008 | $140K | View on EDGAR | |
| - | - | - | - |
GPCR insider trading FAQ
What is the latest insider trade for GPCR?
Structure Therapeutics Inc. (GPCR) had 6 insider filings in the last 90 days, with the most recent on 2026-09-22. The full record for GPCR runs to 43 Form 4 filings, the earliest from 2025-06-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GPCR stock?
No insider purchases of GPCR were filed in the last 90 days.
How many insiders are selling GPCR stock?
11 insider sales of GPCR were filed in the last 90 days, totaling $1.70M.
Where can I see GPCR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GPCR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Crespo Blas Coll view on EDGAR
- - Xichen Lin view on EDGAR
- - Xichen Lin view on EDGAR
- - John Joseph Berrios view on EDGAR
- - Xichen Lin view on EDGAR
- - FMR LLC view on EDGAR
- - Xichen Lin view on EDGAR
- - Xichen Lin view on EDGAR
- - Angus C. Russell view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where GPCR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GPCR with a 7-day demo
- GPCR on your watchlist
- Every GPCR Form 4 filing on record
- Up to 3 months of GPCR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
